Sandoz Group AG
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Public
- Established
- 1986-01-01
- Employees
- 20K
- Market Cap
- $19B
- Website
- http://www.sandoz.com
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Phase 1
Completed
- Conditions
- Psychosis
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 30
- Registration Number
- NCT00946491
To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 48
- Registration Number
- NCT00946465
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
Phase 1
Completed
- Conditions
- HypertensionAngina
- Interventions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 28
- Registration Number
- NCT00946725
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Phase 2
Completed
- Conditions
- Asthma
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 105
- Registration Number
- NCT00927758
- Locations
- πΊπΈ
University of Florida, Gainesville, Florida, United States
πΊπΈCompleWare, Iowa City, Iowa, United States
πΊπΈUniversity of Wisconsin, Madison, Wisconsin, United States
To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 18
- Registration Number
- NCT00913887
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913822
To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets
Phase 1
Completed
- Conditions
- Allergy
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913549
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 36
- Registration Number
- NCT00913783
To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 46
- Registration Number
- NCT00913718
To Demonstrate the Relative Bioavailability of Atenolol Tablets
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Sandoz
- Target Recruit Count
- 24
- Registration Number
- NCT00913965
Β© Copyright 2025. All Rights Reserved by MedPath